BackBiostar Pharmaceuticals Overview

Biostar Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for BSPM.

Quarterly EBIT

-$77.97K
↑ 96.02% YoY

As of Sep 30, 2017

Annual EBIT (TTM)

$3.56M
↑ 111.67% YoY

Trailing 12 months ending Sep 30, 2017

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin